176 related articles for article (PubMed ID: 25187731)
1. In vivo skin fluorescence imaging in young Caucasian adults with early malignant melanomas.
Piérard GE; Hermanns-Lê T; Piérard SL; Dewalque L; Charlier C; Piérard-Franchimont C; Delvenne P
Clin Cosmet Investig Dermatol; 2014; 7():225-30. PubMed ID: 25187731
[TBL] [Abstract][Full Text] [Related]
2. Scrutinizing skinfield melanin patterns in young Caucasian women.
Hermanns-Lê T; Piérard-Franchimont C; Piérard GE
Expert Opin Med Diagn; 2013 Sep; 7(5):455-62. PubMed ID: 23919262
[TBL] [Abstract][Full Text] [Related]
3. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
4. [The sun and malignant melanoma].
Garbe C
Hautarzt; 1992 May; 43(5):251-7. PubMed ID: 1612913
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
6. Streamlining cutaneous melanomas in young women of the Belgian Mosan region.
Hermanns-Lê T; Piérard S
Biomed Res Int; 2014; 2014():320767. PubMed ID: 24716193
[TBL] [Abstract][Full Text] [Related]
7. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Fraser MC; Clark WH; Tucker MA
J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
[TBL] [Abstract][Full Text] [Related]
9. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
11. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population.
Ródenas JM; Delgado-Rodríguez M; Herranz MT; Tercedor J; Serrano S
Cancer Causes Control; 1996 Mar; 7(2):275-83. PubMed ID: 8740740
[TBL] [Abstract][Full Text] [Related]
12. Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation.
Moan J; Cicarma E; Setlow R; Porojnicu AC; Grant WB; Juzeniene A
Dermatoendocrinol; 2010 Jan; 2(1):3-8. PubMed ID: 21547141
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi.
Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG
Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599
[TBL] [Abstract][Full Text] [Related]
14. Mosaic subclinical melanoderma: an Achilles heel for UV-related epidermal carcinogenesis?
Quatresooz P; Petit L; Uhoda I; Pierard-Franchimont C; Pierard GE
Int J Oncol; 2004 Dec; 25(6):1763-7. PubMed ID: 15547715
[TBL] [Abstract][Full Text] [Related]
15. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma in central iran: a 20-year study.
Noorbala MT; Mohammadi S; Noorbala M
Iran Red Crescent Med J; 2013 Aug; 15(8):690-4. PubMed ID: 24578836
[TBL] [Abstract][Full Text] [Related]
17. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
Randi G; Naldi L; Gallus S; Di Landro A; La Vecchia C;
J Invest Dermatol; 2006 Sep; 126(9):2106-10. PubMed ID: 16645584
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in rising trends in cutaneous malignant melanoma in Spain, 1975-98.
Nieto A; Ruiz-Ramos M; Abdel-Kader L; Conde M; Camacho F
Br J Dermatol; 2003 Jan; 148(1):110-6. PubMed ID: 12534603
[TBL] [Abstract][Full Text] [Related]
19. Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.
Hussein MR; Elsers DA; Fadel SA; Omar AE
J Clin Pathol; 2006 Mar; 59(3):316-24. PubMed ID: 16505286
[TBL] [Abstract][Full Text] [Related]
20. In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients.
Zhao C; Snellman E; Jansen CT; Hemminki K
Int J Cancer; 2002 Mar; 98(3):331-4. PubMed ID: 11920582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
